CY1120111T1 - Αντιβακτηριακα παραγωγα 2η-ινδαζολης - Google Patents

Αντιβακτηριακα παραγωγα 2η-ινδαζολης

Info

Publication number
CY1120111T1
CY1120111T1 CY20181100362T CY181100362T CY1120111T1 CY 1120111 T1 CY1120111 T1 CY 1120111T1 CY 20181100362 T CY20181100362 T CY 20181100362T CY 181100362 T CY181100362 T CY 181100362T CY 1120111 T1 CY1120111 T1 CY 1120111T1
Authority
CY
Cyprus
Prior art keywords
indazole
antibacterial derivatives
antibacterial
derivatives
halogen
Prior art date
Application number
CY20181100362T
Other languages
English (en)
Inventor
Jean-Christophe Gauvin
Azely MIRRE
Etienne OCHALA
Jean-Philippe Surivet
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of CY1120111T1 publication Critical patent/CY1120111T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/65031Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/65038Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)

Abstract

Η εφεύρεση σχετίζεται με αντιβακτηριακές ενώσεις του χημικού τύπου I όπου το R1 είναι Η ή το αλογόνο ˙ το R2 είναι αλκυνυλοξυ ή η ομάδα Μ ˙ το R3 είναι Η ή το αλογόνο ˙ το Μ είναι μία από τις ομάδες (Α, Β, C, D), όπου το Α είναι ένας δεσμός, CH2CH2, CH=CH ή C=C και τα R1A, R2A, R3A, R1B και R1C είναι όπως ορίζονται στην αξίωση 1 ˙ και τα άλατα αυτού.
CY20181100362T 2013-09-13 2018-03-30 Αντιβακτηριακα παραγωγα 2η-ινδαζολης CY1120111T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2013058537 2013-09-13
PCT/IB2014/064458 WO2015036964A1 (en) 2013-09-13 2014-09-12 Antibacterial 2h-indazole derivatives

Publications (1)

Publication Number Publication Date
CY1120111T1 true CY1120111T1 (el) 2018-12-12

Family

ID=51688371

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100362T CY1120111T1 (el) 2013-09-13 2018-03-30 Αντιβακτηριακα παραγωγα 2η-ινδαζολης

Country Status (29)

Country Link
US (1) US9802901B2 (el)
EP (1) EP3044211B1 (el)
JP (1) JP6353909B2 (el)
KR (1) KR20160055889A (el)
CN (1) CN105531264B (el)
AR (1) AR097617A1 (el)
AU (1) AU2014319966B2 (el)
BR (1) BR112016007757A8 (el)
CA (1) CA2923146A1 (el)
CL (1) CL2016000568A1 (el)
CY (1) CY1120111T1 (el)
DK (1) DK3044211T3 (el)
EA (1) EA031562B1 (el)
ES (1) ES2662894T3 (el)
HR (1) HRP20180484T1 (el)
HU (1) HUE038519T2 (el)
IL (1) IL244500B (el)
LT (1) LT3044211T (el)
MA (1) MA38948B1 (el)
MX (1) MX361733B (el)
MY (1) MY179283A (el)
PH (1) PH12016500480A1 (el)
PL (1) PL3044211T3 (el)
PT (1) PT3044211T (el)
SG (1) SG11201601889YA (el)
SI (1) SI3044211T1 (el)
TW (1) TWI646084B (el)
UA (1) UA116484C2 (el)
WO (1) WO2015036964A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624206B2 (en) 2013-12-19 2017-04-18 Actelion Pharmaceuticals Ltd Antibacterial 1H-indazole and 1H-indole derivatives
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
JP2017515906A (ja) 2014-05-16 2017-06-15 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 抗菌性キナゾロン−4(3h)−オン誘導体
BR112017010474A2 (pt) 2014-11-19 2017-12-26 Actelion Pharmaceuticals Ltd derivados antibacterianos de benzotiazol
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
MA42679A (fr) * 2015-08-28 2018-07-04 Idorsia Pharmaceuticals Ltd Dérivés de pyrrolidin-2-one annelés antibactériens
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
BR112018073580A2 (pt) * 2016-05-17 2019-03-19 Idorsia Pharmaceuticals Ltd derivados de 6-(buta-1,3-diyn-1-il) benzo [d] tiazol
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
CN113372276B (zh) * 2021-05-25 2022-04-22 三峡大学 吲唑类衍生物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453847A1 (en) 2001-12-05 2004-09-08 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US6806279B2 (en) 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
NZ535158A (en) 2002-03-13 2007-06-29 Array Biopharma Inc N3 alkylated benzimidazole derivatives as MEK inhibitors
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
WO2006063281A2 (en) 2004-12-10 2006-06-15 Emory University 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
BRPI0609719B8 (pt) 2005-03-23 2021-05-25 Hoffmann La Roche derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
JP5539864B2 (ja) 2007-06-12 2014-07-02 アカオゲン,インコーポレーテッド 抗菌剤
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
WO2010135536A2 (en) 2009-05-20 2010-11-25 Ardea Biosciences, Inc. Methods of modulating uric acid levels
WO2011021209A1 (en) 2009-07-07 2011-02-24 Portsmouth Technologies Llc Histone deacetylase inhibitors
JP5671545B2 (ja) * 2009-10-13 2015-02-18 ファイザー・インク 抗菌薬として有用なc結合ヒドロキサム酸誘導体
SI2512474T1 (sl) 2009-12-16 2014-12-31 Pfizer Inc. N-vezani derivati hidroksamske kisline, uporabni kot protibakterijska sredstva
GB2483736B (en) 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
EP2638006A1 (en) 2010-11-10 2013-09-18 Achaogen, Inc. Hydroxamic acid derivatives and their use in the treatment of bacterial infections
US8853213B2 (en) 2011-01-03 2014-10-07 Hanmi Pharm. Co., Ltd Bicyclic compound for modulating G protein-coupled receptors
SG192766A1 (en) * 2011-03-07 2013-09-30 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
CN103717582B (zh) 2011-04-08 2015-09-30 辉瑞大药厂 用作抗菌剂的异*唑衍生物
MX2013011432A (es) * 2011-04-08 2013-12-09 Pfizer Derivados de imidazol, pirazol, y triazol utiles como agentes antibacterianos.
EP2847162A1 (en) 2012-05-09 2015-03-18 Achaogen, Inc. Antibacterial agents
US9624206B2 (en) 2013-12-19 2017-04-18 Actelion Pharmaceuticals Ltd Antibacterial 1H-indazole and 1H-indole derivatives
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
JP2017515906A (ja) 2014-05-16 2017-06-15 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 抗菌性キナゾロン−4(3h)−オン誘導体

Also Published As

Publication number Publication date
MA38948B1 (fr) 2018-04-30
IL244500B (en) 2018-05-31
PH12016500480B1 (en) 2016-05-16
US9802901B2 (en) 2017-10-31
SI3044211T1 (en) 2018-04-30
HRP20180484T1 (hr) 2018-05-04
JP6353909B2 (ja) 2018-07-04
MA38948A1 (fr) 2017-05-31
MX2016003196A (es) 2016-06-02
BR112016007757A8 (pt) 2018-08-14
SG11201601889YA (en) 2016-04-28
PH12016500480A1 (en) 2016-05-16
IL244500A0 (en) 2016-04-21
AU2014319966B2 (en) 2018-11-15
EP3044211B1 (en) 2018-01-03
EA031562B1 (ru) 2019-01-31
WO2015036964A1 (en) 2015-03-19
EP3044211A1 (en) 2016-07-20
AR097617A1 (es) 2016-04-06
MY179283A (en) 2020-11-03
CA2923146A1 (en) 2015-03-19
PT3044211T (pt) 2018-03-21
CN105531264A (zh) 2016-04-27
CL2016000568A1 (es) 2016-11-11
AU2014319966A1 (en) 2016-05-05
UA116484C2 (uk) 2018-03-26
PL3044211T3 (pl) 2018-06-29
CN105531264B (zh) 2018-04-10
LT3044211T (lt) 2018-04-10
TWI646084B (zh) 2019-01-01
EA201600248A1 (ru) 2016-08-31
ES2662894T3 (es) 2018-04-10
TW201542531A (zh) 2015-11-16
KR20160055889A (ko) 2016-05-18
US20160221959A1 (en) 2016-08-04
BR112016007757A2 (pt) 2018-07-10
JP2016530327A (ja) 2016-09-29
DK3044211T3 (en) 2018-03-12
HUE038519T2 (hu) 2018-10-29
MX361733B (es) 2018-12-14

Similar Documents

Publication Publication Date Title
CY1120111T1 (el) Αντιβακτηριακα παραγωγα 2η-ινδαζολης
CY1119585T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινης
CY1121362T1 (el) Παραγωγα της 1,2-διϋδρο-3η- πυρρολo[1,2-c] ιμιδαζολ-3-ονης και η χρηση τους ως αντιβακτηριακοι παραγοντες
CY1121901T1 (el) Ενωσεις τριαζολοπυριμιδινης και χρησεις αυτων
CY1120173T1 (el) Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης
CY1122821T1 (el) Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2
CY1123569T1 (el) Παραγωγα ισοϊνδολινο-1-ονης ως δραστικοτητα θετικου αλλοστερiκου τροποποιητη χολινεργικου μουσκαρινικου μ1 υποδοχεα για τη θεραπεια της νοσου toy alzheimer
CY1122614T1 (el) 11-υδροξυλ-6-υποκατεστημενα-παραγωγα χολικων οξεων και συζευγματα αμινοξεων αυτων ως ρυθμιστες υποδοχεων χ φαρνεσοειδων
CY1121724T1 (el) Ενωσεις για την αντιμετωπιση καρκινου
CY1121549T1 (el) Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων
CY1121792T1 (el) Ετεροκυκλικη ενωση
CY1121804T1 (el) Καινοτομες ενωσεις πυριμιδινης και πυριδινης και η χρηση τους
CY1116192T1 (el) Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων
CY1121677T1 (el) Ενωσεις διμεθυλοβενζοϊκου οξεος
CY1124537T1 (el) Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
CY1124022T1 (el) Σχημα χορηγησης για νιτροκατεχολες
CY1119583T1 (el) Φαινοξυαιθυλο παραγωγα κυκλικης αμινης και η δραστικοτητα τους ως τροποποιητες του ερ4 υποδοχεα
CY1119842T1 (el) Συντηγμενες τρικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις ιντεγκρασης hiv
CY1115945T1 (el) Παραγωγα πυραζολοκινολινονης, η παρασκευη τους και η θεραπευτικη τους χρηση
CY1119425T1 (el) Ενωσεις φαινοξυαιθυλο πιπεριδινης
CY1122563T1 (el) ΑΜΙΔΟΫΠΟΚΑΤΕΣΤΗΜΕΝΑ ΘΕΙΑΖΟΛΙΑ ΩΣ ΔΙΑΜΟΡΦΩΤΕΣ RORγt
CY1123154T1 (el) Παραγοντας ενισχυσης της επιδρασης αποκαταστασης μετα απο νευρικη βλαβη που περιλαμβανει ενα παραγωγο αλκυλαιθερα ή ενα αλας αυτου
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
CY1121626T1 (el) Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου